PSMD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.445800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.010200E-01
Normal-vs-Stage2
5.175600E-01
Normal-vs-Stage3
8.028600E-01
Normal-vs-Stage4
6.520800E-01
Stage1-vs-Stage2
7.142800E-01
Stage1-vs-Stage3
4.710800E-01
Stage1-vs-Stage4
8.249400E-01
Stage2-vs-Stage3
2.846000E-01
Stage2-vs-Stage4
9.707000E-01
Stage3-vs-Stage4
5.333000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.698200E-01
Normal-vs-AfricanAmerican
3.844200E-01
Normal-vs-Asian
3.941600E-01
Caucasian-vs-AfricanAmerican
6.914400E-01
Caucasian-vs-Asian
9.977200E-01
AfricanAmerican-vs-Asian
6.519000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.430800E-01
Normal-vs-Female
4.194800E-01
Male-vs-Female
3.067000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.560800E-01
Normal-vs-Age(41-60Yrs)
2.461200E-01
Normal-vs-Age(61-80Yrs)
7.090200E-01
Normal-vs-Age(81-100Yrs)
5.982600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.059800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.389600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.475600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.331740E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.785600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.622400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.163400E-01
Normal-vs-Daily Drinker
8.294000E-01
Normal-vs-Weekly Drinker
4.929600E-01
Normal-vs-Occasional Drinker
2.736200E-01
Normal-vs-Social Drinker
3.953800E-01
Non Drinker-vs-Daily Drinker
8.319800E-01
Non Drinker-vs-Weekly Drinker
2.455600E-01
Non Drinker-vs-Occasional Drinker
1.450040E-02
Non Drinker-vs-Social Drinker
2.201800E-01
Daily Drinker-vs-Weekly Drinker
3.318000E-01
Daily Drinker-vs-Occasional Drinker
3.117700E-02
Daily Drinker-vs-Social Drinker
2.993000E-01
Weekly Drinker-vs-Occasional Drinker
2.769800E-01
Weekly Drinker-vs-Social Drinker
9.581400E-01
Occasional Drinker-vs-Social Drinker
1.974590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.021400E-01
Normal-vs-Grade 2
9.194000E-01
Normal-vs-Grade 3
9.998200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.600100E-03
Grade 1-vs-Grade 3
8.611600E-04
Grade 1-vs-Grade 4
8.021400E-01
Grade 2-vs-Grade 3
9.981700E-02
Grade 2-vs-Grade 4
9.194000E-01
Grade 3-vs-Grade 4
9.998200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.222800E-01
Normal-vs-NonDiabetic
4.905000E-01
Diabetic-vs-NonDiabetic
6.423800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.396950E-01
Normal-vs-NoPancreatitis
5.805800E-01
Pancreatitis-vs-NoPancreatitis
1.060560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.500800E-01
Normal-vs-N1
5.281000E-01
N0-vs-N1
8.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.785370E-01
Normal-vs-TP53-NonMutant
9.964400E-01
TP53-Mutant-vs-TP53-NonMutant
3.16700000002612E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
